
|

| |
Track the *RXDIA Index |
 |
|
 | Diabetes Stocks (*RXDIA) |
| |
Diabetes Ideas |
|
|
|
Diabetes Performance |
|
|
|
Diabetes Community |
|
| |
|
Index Description: These medical firms have significant exposure to treatments and therapies for diabetes
|
|
|
|
|
Today:
1-month:
All-time:
|
-0.3%
+2.7%
+4.3%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-1.0%
+3.4%
-15.7%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$10.5B
0.0
0.2%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| ARRY |
$4.96 |
-0.13 |
-2.5% |
1,168,187 |
70% |
$593.9M |
- |
57% |
-24% |
No Alerts/News
|
|
|
| BIOD |
$4.76 |
+0.37 |
+8.4% |
1,496,473 |
541% |
$62.3M |
- |
123% |
-4% |
2 Alerts (1 News) - View
|
|
|
| DEPO |
$6.04 |
+0.08 |
+1.3% |
448,622 |
81% |
$336.7M |
- |
23% |
-16% |
1 Alert (0 News) - View
|
|
|
| DXCM |
$22.80 |
+0.24 |
+1.1% |
373,066 |
61% |
$1.5B |
- |
114% |
1% |
1 Alert (0 News) - View
|
|
|
| GNBT |
$0.04 |
0.00 |
-4.3% |
4,180,596 |
90% |
$19.9M |
- |
73% |
-65% |
No Alerts/News
|
|
|
| MNKD |
$6.61 |
-0.94 |
-12.4% |
38,060,395 |
416% |
$2.1B |
- |
269% |
-18% |
3 Alerts (0 News) - View
|
|
|
| NVO |
$161.87 |
+0.17 |
+0.1% |
243,917 |
106% |
$88.0B |
1.4% |
19% |
-17% |
1 Alert (1 News) - View
|
|
|
| PODD |
$31.13 |
+0.35 |
+1.1% |
230,002 |
44% |
$1.6B |
- |
73% |
-0% |
1 Alert (0 News) - View
|
|
|
| SPEX |
$5.74 |
+0.24 |
+4.4% |
4,198 |
117% |
$4.4M |
- |
12% |
-63% |
1 Alert (0 News) - View
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
Biodel Announces Proposed Public Offering of Common Stock BIOD
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 18, 04:13PM from (globenewswire.com) DANBURY, Conn., June 18, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today announced that it is offering to sell,
Flag
Post a comment
Medtronic Saga: Corrupt Science, Belated Warning BMY LLY MDT MRK NVO AZN ABBV
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - June 18, 12:36PM from (ycharts.com) As the result of an unusual effort designed to bolster transparency in clinical trials, two independent analyses have found
Flag
Post a comment
Pipeline vs. Expiring Patents: Eli Lilly’s Future LLY PFE JNJ MRK NVO C
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - June 12, 01:37PM from (ycharts.com) Notwithstanding management promulgations to the contrary, investors remain circumspect about Eli Lilly’s (LLY) ability
Flag
Post a comment
Mid-Day Market Update: Stocks Pare Gains, G-III Apparel Surges On Q1 Results DG GIII ARRY CRM INFI SLCA ET
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 04, 01:24PM from (www.benzinga.com) Midway through trading Tuesday, the Dow traded up 0.01 percent to 15,256.10, while the NASDAQ rose 0.24 percent to 3,473.61.
Flag
Post a comment
Market Wrap for Monday, June 3: Stocks Rise to Start Week AAPL SPY MNKD NMR UUP SODA P GRPN ZNGA TSRO TLT
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 03, 04:13PM from (www.benzinga.com) Despite a very disappointing ISM reading for May which caused volatility in the currency markets, stocks did well to start
Flag
Post a comment
Mid-Morning Market Update: Markets Rise, Cracker Barrel Posts Upbeat Earnings MNKD CLP MAA BMRN DSGX CBRL INFI
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 03, 10:34AM from (www.benzinga.com) Following the market opening Monday, the Dow traded up 0.69 percent to 15,220.16, while the NASDAQ rose 0.12 percent to 3,460.18.
Flag
Post a comment
Drug Used to Treat Kidney Cancer Is Found to Hold Off Relapses of Ovarian Cancer ARRY GSK
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - June 01, 10:42AM from (www.nytimes.com) The study was among many being presented at the annual meeting of the American Society of Clinical Oncology.<img width='1'
Flag
Post a comment
Depomed Fails to Win US Approval for Menopause Drug DEPO
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 31, 07:31PM from (www.bloomberg.com) Depomed Inc. (DEPO) failed to win U.S. approval for a drug to ease hot flashes associated with menopause that regulatory advisers had said was too risky to clear for sale.
Flag
Post a comment
Investing For The Global Diabetes Epidemic BDX LLY MCD WST NVO MNKD DVA RVP SNY PODD
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 31, 02:00PM from (www.investopedia.com) Sadly, diabetes is quickly becoming a global epidemic. Within these grim statistics, investors can find opportunities with
Flag
Post a comment
The Professor Threatening Merck’s No. 1 Drug BMY LLY MRK NVO AZN
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 30, 02:45PM from (ycharts.com) Safety questions about Merck’s (MRK) No. 1-selling drug, Januvia, now have a human face, Dr. Peter C. Butler, a UCLA endocrinologist,
Flag
Post a comment
A Doctor Raises Questions About a Diabetes Drug BMY LLY MRK NVO
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 30, 12:12PM from (www.nytimes.com) Dr. Peter Butler of U.C.L.A. has raised red flags about Merck’s diabetes drug Januvia and others of its class, including
Flag
Post a comment
Square Feet: Drab Office in New Jersey Gets the Cinderella Treatment BMY NVO BLK RLGY
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 28, 07:32PM from (www.nytimes.com) The gut renovation of a dark, outdated 1980s office building in New Jersey shows how aging structures can become glassy corporate
Flag
Post a comment
'Love Hormone' Promises Safer Births After Pfizer Flop PFE MNKD NKTR
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 19, 06:03PM from (www.bloomberg.com) A hormone treatment based on technology used in Pfizer Inc. (PFE)’s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality.
Flag
Post a comment
|
|
|